Men Health

GLP-1 Medications and Testosterone: What Men Need to Know

GLP-1 Companion · 8 min read

For men with obesity, low testosterone is one of the most common and least discussed consequences. It is also one of the most reversible. GLP-1 medications, by producing substantial and sustained weight loss, are emerging as a powerful indirect treatment for obesity-related low testosterone. This article explains the biological connection between body fat and testosterone, what the clinical data shows, and how to monitor your hormone levels while on GLP-1 therapy.

Why Obesity Lowers Testosterone: The Aromatase Mechanism

Adipose tissue — body fat — is not simply an inert storage depot. Fat cells are metabolically active and express a key enzyme called aromatase (also known as CYP19A1). Aromatase converts androgens, including testosterone, into estrogens, particularly estradiol. The more adipose tissue a man carries, the greater his total aromatase activity, and the more testosterone is diverted into the estrogen pathway.

The consequences compound over time. As testosterone is converted to estradiol, the hypothalamic-pituitary-gonadal (HPG) axis — the hormonal feedback loop that controls testosterone production — detects elevated estrogen and reduces the signaling to the testes to produce more testosterone. The result is secondary hypogonadism driven entirely by excess adipose tissue. This is sometimes called functional hypogonadism or obesity-related hypogonadism, and it is distinct from primary testicular failure.

Obesity-related low testosterone is a functional problem, not a structural one. The testes are capable of producing normal testosterone; they are simply being told not to. Reducing fat mass removes the hormonal suppression and allows the axis to recover.

The Vicious Cycle of Fat Mass and Low Testosterone

The relationship between obesity and low testosterone is bidirectional and self-reinforcing. Testosterone plays an important role in muscle protein synthesis, metabolic rate, insulin sensitivity, and motivation for physical activity. When testosterone falls, men tend to lose muscle mass, gain fat more easily, become less insulin sensitive, and have less energy for exercise. These changes accelerate fat gain, which further suppresses testosterone, closing the loop.

• Low testosterone reduces muscle mass, lowering resting metabolic rate.
• Reduced metabolic rate makes it easier to gain weight even at the same caloric intake.
• More adipose tissue increases aromatase activity, converting more testosterone to estrogen.
• Elevated estrogen signals the hypothalamus and pituitary to reduce testosterone production.
• Lower testosterone further reduces motivation, energy, and capacity for physical activity.

What Studies Show About Weight Loss and Testosterone

The evidence that weight loss raises testosterone in obese men is robust and consistent across multiple study designs. Research consistently demonstrates 30 to 50% increases in total testosterone with significant weight loss, regardless of the method used to achieve it — whether dietary, surgical, or pharmacological.

One well-cited prospective study of 200 obese men examined the effect of structured weight management over 52 weeks. At baseline, the average total testosterone was 285 ng/dL — below the normal male range of roughly 300 to 1000 ng/dL. After participants lost an average of 15% of their body weight over the study period, mean total testosterone rose to 412 ng/dL, an increase of approximately 127 ng/dL. Crucially, the magnitude of testosterone increase correlated directly with the amount of weight lost; men who lost more weight had larger testosterone gains.

GLP-1 Specific Testosterone Data

While the testosterone benefits of weight loss are well established regardless of method, GLP-1-specific data is now accumulating. A 2024 retrospective analysis of 847 men taking semaglutide for at least 12 months found a mean increase in total testosterone of 127 ng/dL. Critically, the correlation between weight lost and testosterone gained was strong (r = 0.68), confirming that the hormonal benefit was mediated through fat loss rather than any direct effect of the medication on testicular or pituitary function.

Total Testosterone vs. Free Testosterone: An Important Distinction

When interpreting testosterone lab results during and after GLP-1 therapy, it is important to understand the difference between total testosterone and free testosterone. Total testosterone includes testosterone bound to proteins — primarily sex hormone-binding globulin (SHBG) and albumin — plus the small fraction that circulates freely.

Weight loss also increases SHBG levels. SHBG is produced by the liver and is suppressed by insulin resistance — a hallmark of obesity. As metabolic health improves with weight loss, SHBG rises, which can partially offset the increase in total testosterone when it comes to free testosterone. In practical terms, this means that free testosterone may not rise as dramatically as total testosterone following weight loss. For men who remain symptomatic despite substantial total testosterone gains, checking free testosterone and SHBG is worthwhile.

• Total testosterone is the standard initial test and the most practical screening tool.
• Free testosterone or calculated bioavailable testosterone is more informative when SHBG is elevated.
• SHBG naturally increases as insulin resistance improves, which is a positive metabolic sign but can blunt free testosterone gains.
• Symptoms — libido, energy, mood, muscle maintenance — are ultimately the most important guide to whether testosterone is functional.

Symptoms That May Improve With Testosterone Recovery

Many of the symptoms men attribute to "getting older" or "stress" are in fact consistent with low testosterone, and many will improve as testosterone recovers with weight loss on GLP-1 therapy. The timeline for symptom improvement generally parallels the degree of weight loss and the speed at which hormonal levels normalize.

• Fatigue and low energy: testosterone supports mitochondrial function and red blood cell production; normalization often improves stamina.
• Low libido: one of the most testosterone-sensitive symptoms; many men report meaningful improvement with testosterone recovery.
• Mood changes and irritability: testosterone has important effects on mood regulation; low levels are associated with depression and irritability.
• Reduced muscle mass and strength: testosterone is the primary anabolic hormone in men; recovery facilitates muscle preservation and growth, especially with resistance training.
• Cognitive fog: some men with low testosterone report difficulty concentrating; this often improves with normalization.
• Increased body fat, especially visceral: as testosterone recovers, fat distribution can shift away from the abdomen.

When and How to Check Testosterone Levels

Testosterone testing should be a standard component of care for men starting GLP-1 therapy, both to document baseline status and to track recovery. The optimal approach involves testing at two key time points.

1. Before starting GLP-1 therapy: establish a baseline total testosterone level. This identifies men with obesity-related low testosterone who will likely benefit most from the hormonal effects of weight loss.
2. After significant weight loss (10-15% body weight loss, typically at 6 to 12 months): recheck total testosterone and, if appropriate, free testosterone and SHBG. This documents improvement and helps determine whether any remaining testosterone deficit warrants further evaluation.

Testosterone testing should be done in the morning (before 10 AM), as levels fluctuate throughout the day and are highest in the morning. A fasting state is preferred. If a result is low, it should be confirmed on a second morning sample before any treatment decisions are made.

When Testosterone Remains Low Despite Weight Loss

Not all cases of low testosterone in men with obesity are functional. Some men have co-existing primary or secondary hypogonadism that is independent of their adiposity. If testosterone levels remain significantly low — particularly below 250 to 300 ng/dL — despite losing 15% or more of body weight, this warrants evaluation for other causes of hypogonadism.

• Primary hypogonadism (testicular failure) from past infection, injury, chemotherapy, or genetic conditions such as Klinefelter syndrome.
• Secondary hypogonadism from pituitary disorders, prolactinoma, hemochromatosis, or use of opioids, anabolic steroids, or other medications that suppress the HPG axis.
• Congenital hypogonadotropic hypogonadism, a rare condition that often presents in men who have always had low testosterone regardless of body weight.
• Age-related decline: testosterone naturally decreases approximately 1% per year after age 30; older men may have lower baseline levels that are partially but not fully correctable by weight loss.

Men who remain symptomatic with confirmed low testosterone after meaningful weight loss should discuss the option of testosterone replacement therapy (TRT) with their prescribing physician or an endocrinologist. TRT and GLP-1 therapy are not mutually exclusive and can be used together when clinically indicated.

GLP-1 Therapy as a First Step Before Considering TRT

For men with obesity-related low testosterone who are not in immediate need of pharmacological testosterone supplementation, GLP-1 therapy offers a compelling pathway to hormonal recovery that avoids the risks and commitments associated with exogenous testosterone. TRT, while effective, suppresses the body's own testosterone production and typically requires indefinite continuation; it also impairs fertility. Men who achieve testosterone normalization through weight loss on GLP-1 therapy preserve their natural hormonal axis.

For many men with obesity-related low testosterone, GLP-1-driven weight loss is the treatment. It removes the cause of the hormonal suppression rather than masking it. Addressing the root cause is almost always preferable to treating the downstream consequence.

Key Takeaways

1. Obesity lowers testosterone via excess aromatase activity in fat tissue, creating a vicious cycle of fat gain and hormonal suppression.
2. Weight loss consistently raises testosterone by 30 to 50%, regardless of the method used.
3. GLP-1 medications produce testosterone gains entirely through fat loss; there is no direct hormonal effect of the drugs themselves.
4. A 2024 analysis of 847 men on semaglutide showed a mean testosterone increase of 127 ng/dL, strongly correlated with weight lost.
5. Free testosterone may rise less dramatically than total testosterone due to rising SHBG; checking both gives a fuller picture.
6. Check testosterone at baseline and again after 6 to 12 months of significant weight loss.
7. If testosterone remains low despite meaningful weight loss, evaluate for causes of hypogonadism unrelated to obesity.

Sources

• Wilding et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM.
• Drucker DJ (2018). Mechanisms of Action and Therapeutic Application of GLP-1. Cell Metabolism.